Why Scientific Equity in Women's Health Is 50 Years Overdue
The research gap isn't just unfair—it's costing lives. Here's what needs to change.
Scaling companies from $100M–$2.5B while advancing evidence-driven, accessible women's health solutions.
Professional Headshot
Add to /img/terry-weber-hero.jpg
A career spent transforming companies, modernizing legacy industries, building diverse high-performing teams, and advancing women's health research equity. From scaling founder-led startups to repositioning Fortune 500 divisions, I bring operational excellence, strategic clarity, and an unwavering commitment to evidence-based innovation.
Former CEO: Biote Medical • Amen Clinics • BrainMD
Measurable outcomes across healthcare, retail, and automotive industries.
Led Biote Medical through explosive growth, IPO readiness, and category leadership in hormone optimization therapy. Expanded Amen Clinics from regional provider to national brand.
Transformed legacy automotive dealerships with modern operational systems, digital infrastructure, and customer-centric processes that drove double-digit growth.
Spearheaded early e-commerce expansion at Frederick's of Hollywood, building digital sales channels that positioned the brand for the internet age.
Turning around underperforming organizations, repositioning brands, and scaling founder-led companies without losing their soul. Building cultures where accountability meets compassion.
Championing scientific equity in women's health research and advancing evidence-based hormone optimization therapies that have been overlooked for decades.
Designing and implementing scalable operational systems across industries—from clinic networks to dealership groups to e-commerce platforms.
Building diverse, high-performing teams with clear succession pathways. Creating leadership pipelines that outlast any single executive tenure.
Biote Medical — Irving, TX
Amen Clinics & BrainMD — Costa Mesa, CA
Multiple Automotive Retail Groups
Frederick's of Hollywood
Robert Allen Fabrics
Various Organizations
SEC-qualified with deep experience in strategic transformation, financial oversight, and cross-industry innovation.
Guiding organizations through pivotal transitions—turnarounds, scale-ups, digital transformation, and market repositioning.
P&L management across revenue ranges from $50M to $2.5B. EBITDA optimization, capital allocation, and IPO preparation.
Developing leadership pipelines and governance frameworks that ensure organizational continuity and sustainable growth.
Most Inspiring People in Life Sciences
Women-Led Companies
Industry Recognition
USA Today, NY Times, Forbes, Fast Company, Business Insider
Thoughts on leadership, healthcare innovation, and women's health equity.
The research gap isn't just unfair—it's costing lives. Here's what needs to change.
How to bring operational discipline without destroying what made the company special.
Cross-industry insights that transformed how I approach operational excellence.
Interested in board opportunities, speaking engagements, or discussing healthcare innovation?